Clinical Trial Update: A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity [Phase 4]

View source ↗

Summary

Phase 4 clinical trial in India evaluating tirzepatide for adults with type 2 diabetes mellitus or obesity; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• MOUNJARO (tirzepatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2, Obesity | Phase 4 | Status: RECRUITING